NCT02873819 — Squamous Cell Carcinoma of the Oral Cavity trial site landscape

Public-registry site landscape for NCT02873819, a Squamous Cell Carcinoma of the Oral Cavity study sponsored by Gliknik Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT02873819 (registry record)
Sponsor	Gliknik Inc.
Condition(s)	Squamous Cell Carcinoma of the Oral Cavity
Phase	PHASE2
Listed sites	33
Site countries	United States, Hungary, Poland, Russia, Serbia, Spain, Ukraine

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT02873819 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.